PRICE T ROWE ASSOCIATES INC /MD/

Position in ABSI — Absci Corp

CIK 80255 BALTIMORE, MD

Position in ABSI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$17,269,018

+$16,916,329 QoQ

Shares Held

1,489,993

+1167.4% QoQ

Ownership

0.868%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#21

of 195 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. ABSI ranks #100 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	SRRK	Scholar Rock Holding Corp	6,794,837	$373,716,035

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,269,018	1,489,993	+1167.4%	Shares	Sole	2026-08-14
2026-03-31	$352,689	117,563	-94.5%	Shares	Defined	2026-05-15
2025-12-31	$7,524,672	2,156,067	+2955.4%	Shares	Sole	2026-02-17
2025-09-30	$214,520	70,566	+29.0%	Shares	Defined	2025-11-14
2025-06-30	$140,586	54,703	+56.3%	Shares	Defined	2025-08-14
2025-03-31	$87,832	34,993	+19.3%	Shares	Defined	2025-05-14
2024-12-31	$76,852	29,333	+14.6%	Shares	Defined	2025-02-14
2024-09-30	$97,738	25,586	0.0%	Shares	Defined	2024-11-14
2024-06-30	$78,804	25,586	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.